{"pmid":32306751,"title":"Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.","text":["Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.","Exp Biol Med (Maywood)","Jogalekar, Manasi P","Veerabathini, Anurag","Gangadaran, Prakash","32306751"],"journal":"Exp Biol Med (Maywood)","authors":["Jogalekar, Manasi P","Veerabathini, Anurag","Gangadaran, Prakash"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32306751","week":"202017|Apr 20 - Apr 26","doi":"10.1177/1535370220920540","keywords":["2019-ncov","covid-19","china","mers-cov","sars-cov","sars-cov-2","wuhan","coronavirus"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1664632501464727554,"score":8.518259,"similar":[{"pmid":31991541,"pmcid":"PMC7077245","title":"Return of the Coronavirus: 2019-nCoV.","text":["Return of the Coronavirus: 2019-nCoV.","The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.","Viruses","Gralinski, Lisa E","Menachery, Vineet D","31991541"],"abstract":["The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus."],"journal":"Viruses","authors":["Gralinski, Lisa E","Menachery, Vineet D"],"date":"2020-01-30T11:00:00Z","year":2020,"_id":"31991541","week":"20205|Jan 27 - Feb 02","doi":"10.3390/v12020135","keywords":["2019-ncov","mers-cov","sars-cov","wuhan","wuhan pneumonia","coronavirus","emerging viruses","novel cov"],"source":"PubMed","topics":["Transmission","Mechanism","Prevention"],"weight":1,"_version_":1664640875413635072,"score":77.47084},{"pmid":32247050,"pmcid":"PMC7118633","title":"Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.","text":["Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.","BACKGROUND: The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively summarized to help optimize control measures and make therapeutic decisions. METHODS: Based on recently published literatures, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV) infection. RESULTS: The genome of 2019-nCoV partially resembled SARS-CoV and MERS-CoV, and indicating a bat origin. The COVID-19 generally had a high reproductive number, a long incubation period, a short serial interval and a low case fatality rate (much higher in patients with comorbidities) than SARS and MERS. Clinical presentation and pathology of COVID-19 greatly resembled SARS and MERS, with less upper respiratory and gastrointestinal symptoms, and more exudative lesions in post-mortems. Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible). CONCLUSION: The initial experience from the current pandemic and lessons from the previous two pandemics can help improve future preparedness plans and combat disease progression.","Int J Infect Dis","Xie, Mingxuan","Chen, Qiong","32247050"],"abstract":["BACKGROUND: The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively summarized to help optimize control measures and make therapeutic decisions. METHODS: Based on recently published literatures, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV) infection. RESULTS: The genome of 2019-nCoV partially resembled SARS-CoV and MERS-CoV, and indicating a bat origin. The COVID-19 generally had a high reproductive number, a long incubation period, a short serial interval and a low case fatality rate (much higher in patients with comorbidities) than SARS and MERS. Clinical presentation and pathology of COVID-19 greatly resembled SARS and MERS, with less upper respiratory and gastrointestinal symptoms, and more exudative lesions in post-mortems. Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible). CONCLUSION: The initial experience from the current pandemic and lessons from the previous two pandemics can help improve future preparedness plans and combat disease progression."],"journal":"Int J Infect Dis","authors":["Xie, Mingxuan","Chen, Qiong"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32247050","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijid.2020.03.071","keywords":["2019-ncov","covid-19","mers-cov","sars-cov","sars-cov-2"],"source":"PubMed","topics":["Mechanism","Diagnosis","Treatment","Prevention"],"weight":1,"e_drugs":["remdesivir","tocilizumab","Chloroquine"],"_version_":1664638040084054016,"score":73.805855},{"pmid":32050635,"pmcid":"PMC7077337","title":"Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.","text":["Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.","In early December 2019 a cluster of cases of pneumonia of unknown cause was identified in Wuhan, a city of 11 million persons in the People's Republic of China. Further investigation revealed these cases to result from infection with a newly identified coronavirus, termed the 2019-nCoV. The infection moved rapidly through China, spread to Thailand and Japan, extended into adjacent countries through infected persons travelling by air, eventually reaching multiple countries and continents. Similar to such other coronaviruses as those causing the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), the new coronavirus was reported to spread via natural aerosols from human-to-human. In the early stages of this epidemic the case fatality rate is estimated to be approximately 2%, with the majority of deaths occurring in special populations. Unfortunately, there is limited experience with coronavirus infections during pregnancy, and it now appears certain that pregnant women have become infected during the present 2019-nCoV epidemic. In order to assess the potential of the Wuhan 2019-nCoV to cause maternal, fetal and neonatal morbidity and other poor obstetrical outcomes, this communication reviews the published data addressing the epidemiological and clinical effects of SARS, MERS, and other coronavirus infections on pregnant women and their infants. Recommendations are also made for the consideration of pregnant women in the design, clinical trials, and implementation of future 2019-nCoV vaccines.","Viruses","Schwartz, David A","Graham, Ashley L","32050635"],"abstract":["In early December 2019 a cluster of cases of pneumonia of unknown cause was identified in Wuhan, a city of 11 million persons in the People's Republic of China. Further investigation revealed these cases to result from infection with a newly identified coronavirus, termed the 2019-nCoV. The infection moved rapidly through China, spread to Thailand and Japan, extended into adjacent countries through infected persons travelling by air, eventually reaching multiple countries and continents. Similar to such other coronaviruses as those causing the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), the new coronavirus was reported to spread via natural aerosols from human-to-human. In the early stages of this epidemic the case fatality rate is estimated to be approximately 2%, with the majority of deaths occurring in special populations. Unfortunately, there is limited experience with coronavirus infections during pregnancy, and it now appears certain that pregnant women have become infected during the present 2019-nCoV epidemic. In order to assess the potential of the Wuhan 2019-nCoV to cause maternal, fetal and neonatal morbidity and other poor obstetrical outcomes, this communication reviews the published data addressing the epidemiological and clinical effects of SARS, MERS, and other coronavirus infections on pregnant women and their infants. Recommendations are also made for the consideration of pregnant women in the design, clinical trials, and implementation of future 2019-nCoV vaccines."],"journal":"Viruses","authors":["Schwartz, David A","Graham, Ashley L"],"date":"2020-02-14T11:00:00Z","year":2020,"_id":"32050635","week":"20207|Feb 10 - Feb 16","doi":"10.3390/v12020194","keywords":["2019-ncov","china","mers-cov","middle east respiratory syndrome","sars-cov","wuhan coronavirus","wuhan coronavirus outbreak","coronavirus","emerging infection","epidemic","maternal death","maternal morbidity","maternal mortality","pneumonia","pregnancy","pregnancy complications","severe acute respiratory syndrome"],"source":"PubMed","topics":["Treatment"],"weight":1,"locations":["Wuhan","China","Thailand","Japan","Wuhan"],"countries":["China","Thailand","Japan"],"countries_codes":["CHN|China","THA|Thailand","JPN|Japan"],"_version_":1664640875309826048,"score":72.07237},{"pmid":32106567,"pmcid":"PMC7150947","title":"Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.","text":["Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.","The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an imminent need to better understand this new virus and to develop ways to control its spread. In this study, we sought to gain insights for vaccine design against SARS-CoV-2 by considering the high genetic similarity between SARS-CoV-2 and SARS-CoV, which caused the outbreak in 2003, and leveraging existing immunological studies of SARS-CoV. By screening the experimentally-determined SARS-CoV-derived B cell and T cell epitopes in the immunogenic structural proteins of SARS-CoV, we identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins. As no mutation has been observed in these identified epitopes among the 120 available SARS-CoV-2 sequences (as of 21 February 2020), immune targeting of these epitopes may potentially offer protection against this novel virus. For the T cell epitopes, we performed a population coverage analysis of the associated MHC alleles and proposed a set of epitopes that is estimated to provide broad coverage globally, as well as in China. Our findings provide a screened set of epitopes that can help guide experimental efforts towards the development of vaccines against SARS-CoV-2.","Viruses","Ahmed, Syed Faraz","Quadeer, Ahmed A","McKay, Matthew R","32106567"],"abstract":["The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an imminent need to better understand this new virus and to develop ways to control its spread. In this study, we sought to gain insights for vaccine design against SARS-CoV-2 by considering the high genetic similarity between SARS-CoV-2 and SARS-CoV, which caused the outbreak in 2003, and leveraging existing immunological studies of SARS-CoV. By screening the experimentally-determined SARS-CoV-derived B cell and T cell epitopes in the immunogenic structural proteins of SARS-CoV, we identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins. As no mutation has been observed in these identified epitopes among the 120 available SARS-CoV-2 sequences (as of 21 February 2020), immune targeting of these epitopes may potentially offer protection against this novel virus. For the T cell epitopes, we performed a population coverage analysis of the associated MHC alleles and proposed a set of epitopes that is estimated to provide broad coverage globally, as well as in China. Our findings provide a screened set of epitopes that can help guide experimental efforts towards the development of vaccines against SARS-CoV-2."],"journal":"Viruses","authors":["Ahmed, Syed Faraz","Quadeer, Ahmed A","McKay, Matthew R"],"date":"2020-02-29T11:00:00Z","year":2020,"_id":"32106567","week":"20209|Feb 24 - Mar 01","doi":"10.3390/v12030254","keywords":["2019 novel coronavirus","2019-ncov","b cell epitopes","covid-19","coronavirus","mers-cov","sars-cov","sars-cov-2","t cell epitopes","vaccine"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875112693761,"score":71.34221},{"pmid":32072569,"title":"2019 Novel coronavirus: where we are and what we know.","text":["2019 Novel coronavirus: where we are and what we know.","There is a current worldwide outbreak of a new type of coronavirus (2019-nCoV), which originated from Wuhan in China and has now spread to 17 other countries. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak sites and from laboratories supporting the investigation. This paper aggregates and consolidates the virology, epidemiology, clinical management strategies from both English and Chinese literature, official news channels, and other official government documents. In addition, by fitting the number of infections with a single-term exponential model, we report that the infection is spreading at an exponential rate, with a doubling period of 1.8 days.","Infection","Cheng, Zhangkai J","Shan, Jing","32072569"],"abstract":["There is a current worldwide outbreak of a new type of coronavirus (2019-nCoV), which originated from Wuhan in China and has now spread to 17 other countries. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak sites and from laboratories supporting the investigation. This paper aggregates and consolidates the virology, epidemiology, clinical management strategies from both English and Chinese literature, official news channels, and other official government documents. In addition, by fitting the number of infections with a single-term exponential model, we report that the infection is spreading at an exponential rate, with a doubling period of 1.8 days."],"journal":"Infection","authors":["Cheng, Zhangkai J","Shan, Jing"],"date":"2020-02-20T11:00:00Z","year":2020,"_id":"32072569","week":"20208|Feb 17 - Feb 23","doi":"10.1007/s15010-020-01401-y","keywords":["2019-ncov","covid-19","china","clinical guideline","coronavirus","epidemiology","literature review","literature survey","novel coronavirus","review","virology","wuhan"],"source":"PubMed","topics":["Mechanism","Epidemic Forecasting","Treatment","Transmission"],"weight":1,"locations":["Wuhan","China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875255300098,"score":69.18749}]}